Myrexis, Inc.
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY13 | FY12 | FY11 | FY10 | |
|---|---|---|---|---|
| Revenue | — | — | $185,000 | $90,000 |
| Operating income | −$3.2M | −$31.8M | −$40.5M | −$48.1M |
| Net income | −$3.2M | −$31.2M | −$38.7M | −$47.0M |
| Total assets | $1.2M | $91.7M | $121.3M | — |
| Total liabilities | — | — | — | — |
| Equity | $1.2M | $89.4M | $118.0M | $149.9M |
| EPS (diluted) | — | — | — | — |
| Shares out. | 34.5M | 26.8M | 26.1M | — |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2013- Operating margin
- —
- Net margin
- —
- Return on equity
- −278.4%
- Return on assets
- −261.8%
- Return on capital (ROCE)
- −276.1%
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $0.03
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2013- Accruals / assets
- 786.9%high accruals
- Piotroski F-Score
- 0/6weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 warning● 0 good- Negative operating cash flow
- High accruals — earnings-quality risk
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Couchman Jonathan10% owner | Aug 13, 2021 | Sell | 50,000 | $0.39 |
| Couchman Jonathan10% owner | Aug 24, 2020 | Sell | 52,100 | $0.18 |
| Couchman Jonathan10% owner | Aug 5, 2020 | Buy | 506,292 | $0.20 |
| Henderson John TDirector | Jan 18, 2013 | Option exercise | 7,500 | $1.07 |
| First Eagle Investment Management, Llc10% owner | Nov 2, 2012 | Sell | 42,000 | $2.38 |
| First Eagle Investment Management, Llc10% owner | Nov 1, 2012 | Sell | 35,000 | $2.37 |
| Kendell AndreaOfficer — Chief Financial Officer | Sep 25, 2012 | Sell | 693 | $2.34 |
| Kendell AndreaOfficer — Chief Financial Officer | Jul 2, 2012 | Grant | 20,000 | $0.00 |
| Aryeh JasonDirector | Jun 18, 2012 | Buy | 3,000 | $2.29 |
| Aryeh JasonDirector | Jun 14, 2012 | Buy | 4,000 | $2.36 |
| Aryeh JasonDirector | Jun 7, 2012 | Buy | 1,116 | $2.40 |
| Aryeh JasonDirector | May 30, 2012 | Buy | 4,020 | $2.46 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Modified shareholder rights · Amended charter or bylaws · Shareholder voteApr 29, 2013
- Director / officer change · Other material eventApr 18, 2013
- Entered a material agreement · Unregistered equity sale · Director / officer changeMar 5, 2013
- Other material eventFeb 28, 2013
- Director / officer changeFeb 20, 2013
- Changed auditorFeb 8, 2013
- Delisting / listing-standard notice · Director / officer change · Other material eventJan 28, 2013
- Entered a material agreement · Director / officer changeDec 21, 2012
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 4OWNERSHIP DOCUMENTAug 17, 2021
- 4OWNERSHIP DOCUMENTAug 26, 2020
- 4OWNERSHIP DOCUMENTAug 6, 2020
- 3OWNERSHIP DOCUMENTAug 6, 2020
- 4/AOWNERSHIP DOCUMENTMar 31, 2020
- 3OWNERSHIP DOCUMENTMar 31, 2020
- 15-12BJul 31, 2013
- 10-K/AJul 26, 2013
- 10-KFORM 10-KJul 17, 2013
- AWJul 15, 2013
- EFFECTJul 11, 2013
- EFFECTJul 11, 2013
- POS AMJul 11, 2013
- POS AMJul 11, 2013
- S-8 POSJul 2, 2013
Corporate family
Spun off from Myriad GeneticsMYGN · Jun 30, 2009
From the spin-off filings we track. Follow a company to walk its own history.
Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.